Table 1:
Patient, disease, and treatment characteristics
| NB characteristics | OMA Syndrome Management | ||||||
|---|---|---|---|---|---|---|---|
| Number | Gender | Age at diagnosis of NB (months) | Stage | Histology | Treatment | Tx duration (months) | OMA Syndrome Relapse |
| 1 | F | 9 | 1 | Favorable | I, A, R | 96 | Y |
| 2 | M | 9 | 1 | Favorable | I, A, R, C | 48 | Y |
| 3 | M | 11 | 1 | Favorable | I, A, R, C | 72 | Y |
| 4 | M | 14 | 1 | Favorable | I, A, D, R | 20 | N |
| 5 | F | 15 | 1 | Favorable | I, A, R | 72 | Y |
| 6 | F | 16 | 2B | Favorable | I, A, D, R, C | 48 | Y |
| 7 | M | 16 | 4 | Unfavorable | I, A, D, R | Ongoing | N |
| 8 | F | 17 | 1 | Favorable | I, A, R, C | Transfer | N |
| 9 | M | 18 | 1 | Favorable | I, A, R | 36 | N |
| 10 | F | 18 | 1 | Favorable | I, A, R, C | 60 | Y |
| 11 | F | 20 | 1 | Unfavorable | I, A, D, R | 36 | N |
| 12 | F | 21 | 1 | Favorable | I, A | 29 | N |
| 13 | F | 21 | 1 | Favorable | I, A, D, R | Transfer | N |
| 14 | F | 21 | 1 | Not determined | I, A, R | 23 | N |
Abbreviations: I, IVIg; A, ACTH; R, Rituximab; D, Dexamethasone; C, Cyclophosphamide.